NOVT - Novanta Inc Debt to Book Capitalization Ratio

Corporate company logo of Novanta Inc. (NOVT)

Novanta Inc. (NOVT) generates revenue by creating precision systems for industry and healthcare, including motors for surgical robots and DNA analyzers. Demand for its optics is moderately subject to market cycles, with the indicator standing at 0.19. Serving as the primary valuation tool, this price chart visualizes the asset's dynamics. A high barrier to entry is maintained through an extensive patent portfolio for sensors and lasers.

Novanta Inc. - NOVT Debts to Book Capitalization (period 07/04/2022 - 10/27/2026)
Flagship merchandise of Novanta Photonics

The dynamics of the total debt-to-net assets ratio reflect the sensitivity of the capital structure to operational flows, measuring the ability of equity to cover borrowed obligations. For Novanta Inc. (NOVT), with its mixed profile of medical and industrial assets, the company's balance sheet financial leverage on GURU.Markets serves as an indicator of resilience to recessions in the industrial sector, preventing the risk of business overheating.

Competitors of Novanta Inc.

DXCM: Debts to Book Capitalization|penumbrainc.com - Debts to Book Value|Debt to Book Capitalization Ratio Haemonetics (HAE)|INSP - Debt to Net Assets Ratio|PRCT: Debts to Book Capitalization|CNMD (CONMED Inc.) - Debts to Book Capitalization|Debt to Book Capitalization Ratio Pulse Biosciences, Inc. PLSE|Debts to Book Capitalization Ratio inmodemd.com|Picard Medical - Debts to Book Capitalization|Debts to Book Value Surmodics Inc SRDX|Debt to Book Value SENS (senseonics.com)|NPCE - Debts to Book Capitalization|Debt to Book Value Tactile Systems Technology Inc. TCMD|SNWV - Debt to Book Capital|Outset Medical - Debts to Book Capitalization|Electromed (ELMD) - Debts to Net Assets|Debts to Book Capitalization LNSR|Debt to Book Value AVITA Medical Inc (RCEL)|Profound Medical Corp. (PROF) - Debt to Book Value|Debt to Net Assets Ratio BDMD (bairdmed.com)|EDAP TMS - Debt to Book Capitalization Ratio|Debt to Book Value Apyx Medical Corp APYX|ICCM (IceCure Medical, Ltd.) - Debts to Book Capitalization|LUNG - Debts to Book Value|Debts to Book Capitalization telabio.com|CytoSorbents Corporation (CTSO) - Debt to Book Value Ratio|SRTS: Debts to Book Capitalization|Debts to Net Assets Zynex Medical|Debts to Book Capitalization ECOR (electroCore, Inc.)|Debt to Book Value vicarioussurgical.com (RBOT)|Debts to Book Capitalization IINN (Inspira Technologies)|seastarmedical.com - Debts to Book Capitalization|IRIX - Debt to Book Capitalization Ratio|Intelligent Bio Solutions (INBS) - Debt to Book Capitalization Ratio|Debt to Book Value beyondair.net XAIR|Profusa, Inc (PFSA) - Debt to Net Assets Ratio|Debts to Book Capitalization SSKN (STRATA Skin Sciences Inc.)|Debts to Book Value GCTK|NAOV: Debt to Book Capitalization Ratio|Debt to Net Assets Venus Concept Inc VERO|Debt to Book Value NUWE (CHF Solutions)|Debts to Book Capitalization Aethlon Medical Corp AEMD|Debts to Book Capitalization ASXC (TransEnterix)|AVGR: Debts to Net Assets|Debt to Book Capitalization Ratio Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio KNW|Debt to Book Value Inari Medical Corp|Nevro Corp. - Debts to Book Capitalization|Debts to Book Value RSLS (reshapelifesciences.com)|SILK - Debt to Book Capitalization Ratio